Citigroup
SLXP

Citigroup’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Citigroup’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-16,300
Closed -$2.82M – 8117
2015
Q1 		$2.82M Buy
16,300
+15,800
+3,160% +$2.32M ﹤0.01% 2192
2014
Q4 		$57K Buy
+500
New +$60.6K ﹤0.01% 5618

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Citigroup's SLXP Position: Q2 2015 in Review

Citigroup sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 47,030 shares — an estimated $8.13M sold.

Citigroup first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $8.13M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Citigroup reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Citigroup sold 47,030 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $8.13M.
  • Citigroup first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Citigroup's SALIX PHARMACEUTICALS LTD DEL position peaked at $8.13M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Citigroup's 13F filing for Q2 2015, filed 13 Aug 2015.